CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- 4 Planned sale Chief Operating Officer sold 7,514 shares at an average $31.82 ($239,123)
- 4 Open-market sale Director sold 40,000 shares at an average $35.05 ($1,401,973)
- 4 Open-market sale Director sold 15,000 shares at $35.07 ($526,001)
- 4 Planned sale Chief Financial Officer sold 20,000 shares at $35.05 ($701,092)
- 4 Planned sale Chief Operating Officer sold 10,000 shares at $34.05 ($340,458)
- 4 Planned sale Chief Operating Officer sold 5,000 shares at an average $30.53 ($152,632)
- 4 Planned sale Kelsey Stephen Michael sold 33,332 shares at an average $30.80 ($1,026,481)
- 4 Planned sale General Counsel sold 1,500 shares at $26.02 ($39,030)
- 4 Open-market sale Kelsey Stephen Michael sold 2,102 shares at $24.89 ($52,321)
- 4 Open-market sale Chief Operating Officer sold 2,102 shares at $24.89 ($52,321)
- 4 Open-market sale Chief Financial Officer sold 1,249 shares at $24.89 ($31,089)
- 4 Open-market sale General Counsel sold 1,239 shares at $25.14 ($31,148)
- 4 Grant or award Director acquired 5,200 shares (grant or award)
- 4 Grant or award Director acquired 5,200 shares (grant or award)
- 4 Grant or award Director acquired 5,200 shares (grant or award)
- 4 Grant or award Director acquired 5,200 shares (grant or award)
- 4 Grant or award Director acquired 5,200 shares (grant or award)
- 4 Grant or award Director acquired 5,200 shares (grant or award)
- 4 Grant or award Director acquired 5,200 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 12 of 21 · 414 filings